comparemela.com

Abionyx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ABIONYX Pharma: Monthly statement of total voting rights and shares forming the company s share capital

Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:

Mecklenburg vorpommernStefan klotterArthur rouillNicolas fossiezLouis victor delouvrierFrench financial markets authorityFrench commercial codeGeneral regulationsEuronext parisVictor delouvrierStabile ertrChart profi stefan klotterBlue chips

ABIONYX Pharma Provides Further Details on the Setting up of Its Equity-Linked Financing Facility

Regulatory News: ABIONYX Pharma, (FR0012616852 ABNX PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the

France generalLouis victor delouvrierLuc demarreNicolas fossiezArthur rouillCyrille tupinEuropean unionRegulatory newsVictor delouvrierGefallene big techs

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company s Share Capital

Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:

Nicolas fossiezArthur rouillLouis victor delouvrierFrench financial markets authorityFrench commercial codeGeneral regulationsEuronext parisVictor delouvrier

ABIONYX Pharma Announces Its 2022 Full-year Financial Results

2022 revenues: €5.3 million Reduction of the annual operating loss Cash position of €4 million as of December 31, 2022 Continued clinical development following the succession

France generalNicolas fossiezValutazioni biologichee farmacologicheLouis victor delouvrierIris pharmaArthur rouillUniversity of bariEuropean medicines agencyDrug administrationValutazioni biologicheClinical trialsInternal medicineCompassionate access authorizationOrphan drug designationVictor delouvrierDiese gold aktie

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company s Share Capital

Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:

Dennis riedlNicolas fossiezLouis victor delouvrierFrench financial markets authorityFrench commercial codeGeneral regulationsEuronext parisVictor delouvrier

vimarsana © 2020. All Rights Reserved.